Daniel J Berlau Selected Research

Daniel J Berlau Research Topics

7	Dementia (Dementias) 01/2018 - 08/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2007
3	Cognitive Dysfunction 01/2018 - 08/2007
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 02/2019
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 05/2020 - 04/2017
2	Pain (Aches) 03/2019 - 01/2018
2	Amyloid Plaque 11/2013 - 08/2007
2	Shock 01/2006 - 11/2003
1	Delirium 01/2022
1	Autism Spectrum Disorder 01/2021
1	Multiple Sclerosis 01/2018
1	Inflammation (Inflammations) 01/2018
1	Fibromyalgia (Fibrositis) 01/2018
1	Crohn Disease (Crohn's Disease) 01/2018
1	Chronic Pain 01/2018
1	Alcoholism (Alcohol Abuse) 01/2018
1	Hippocampal Sclerosis 12/2011

4	Apolipoproteins E (ApoE)IBA 11/2013 - 08/2007
3	ApolipoproteinsIBA 11/2013 - 08/2007
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2018
2	Opioid Analgesics (Opioids)IBA 03/2019 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 11/2013 - 12/2011
2	Apolipoprotein E4IBA 11/2011 - 03/2009
2	Apolipoprotein E2IBA 03/2009 - 08/2007
1	MelatoninIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 05/2020
1	DystrophinIBA 05/2020
1	Analgesics (Analgesic Drugs)IBA 03/2019
1	CatecholaminesIBA 02/2019
1	Naltrexone (ReVia)FDA LinkGeneric 01/2018
1	SynucleinsIBA 12/2011
1	Apolipoprotein E3IBA 03/2009
1	Protein Isoforms (Isoforms)IBA 08/2007
1	AnisomycinIBA 01/2006
1	Protein Synthesis InhibitorsIBA 01/2006
1	MuscimolIBA 11/2003

2	Drug Therapy (Chemotherapy) 05/2020 - 04/2017
2	Therapeutics 05/2020 - 02/2019
1	Critical Care (Surgical Intensive Care) 01/2022